JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,997,000 | +17.7% | 90,000 | 0.0% | 0.13% | +20.0% |
| Q4 2016 | $1,697,000 | -37.2% | 90,000 | 0.0% | 0.11% | -33.3% |
| Q3 2016 | $2,701,000 | -21.9% | 90,000 | 0.0% | 0.16% | -22.2% |
| Q2 2016 | $3,460,000 | +0.9% | 90,000 | 0.0% | 0.21% | +10.4% |
| Q1 2016 | $3,428,000 | -13.4% | 90,000 | 0.0% | 0.19% | -3.0% |
| Q4 2015 | $3,957,000 | – | 90,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,864,174 | $83,627,000 | 94.97% |
| Crestline Management, LP | 9,348,799 | $419,387,000 | 58.30% |
| Omega Fund Management, LLC | 1,074,612 | $48,207,000 | 27.27% |
| PECONIC PARTNERS LLC | 570,000 | $25,570,000 | 4.12% |
| SIB LLC | 100,000 | $4,486,000 | 3.22% |
| Cormorant Asset Management, LP | 375,000 | $16,823,000 | 2.97% |
| BB BIOTECH AG | 2,055,000 | $92,187,000 | 2.55% |
| Clarius Group, LLC | 117,896 | $5,289,000 | 2.23% |
| Monashee Investment Management LLC | 122,000 | $5,473,000 | 2.07% |
| Iguana Healthcare Management, LLC | 150,000 | $6,730,000 | 1.86% |